Skip to main content
. 2020 May 13;9(5):1456. doi: 10.3390/jcm9051456

Figure 4.

Figure 4

Anticoagulation/platelet inhibition regime in patients with CHD-associated PAH at inclusion and at last observation. Abbreviations: CHD, congenital heart disease; NOAC, non-vitamin K antagonists; vit, vitamin; PAH, pulmonary arterial hypertension